RxDoctor Payments DataLook up a doctor →

IGE025A_XOLAIR _RESPIRATORY: payments to doctors

Payments that named IGE025A_XOLAIR _RESPIRATORY as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$33K
Providers
5
Transactions
16
Average per transaction
$2,042

The per-transaction average — $2,042 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5 providers the average total is $6,536, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis Pharma AG$32,679100.0%
← All drugs & devices